Could COVID-19 vaccine save us from pandemic?


This image was accessed via Google Images under the Creative Commons License

The FDA authorized the COVID-19 vaccine from the Pfizer-BioNTech company on Friday, December 11, and the first vaccines to be given to United States citizens were received by health care workers on Monday, December 14.

The 2020 COVID-19 pandemic has taken a toll on peoples’ everyday lives, including their education and interaction with loved ones. So, a safe and well-developed vaccine will give the world a chance at returning back to normal. 

In the United States, an authorized vaccine to help mitigate the effects of COVID-19 has recently been made available. The CDC has been working alongside health departments to develop vaccination plans for the entire population, but the first round of vaccines will go to essential workers. The next round will go to those who are high risk, and the general public will be the last to be vaccinated. 

The U.S. vaccine safety system ensured that every vaccine developed was as safe as possible. The safety of the COVID-19 vaccine is our one of our government’s priorities right now.

The CDC is partnering with healthcare associations to make sure any COVID-19 vaccination programs are flexible and are able to accommodate different vaccines and scenarios, depending on the state people live in. State health departments are critical to making sure that vaccines are available to every community.

The government is using U.S. taxpayer dollars to purchase the vaccines so that they will be available to everyone. However, vaccine providers such as doctors’ offices, retail pharmacies, hospitals and health centers will be able to charge administration fees for administering the shot to someone. The patient’s public or private insurance company or the Health Resources and Services Administration’s Provider Relief Fund can reimburse these fees. 

Now, in the early stages of the vaccine, there is a limited supply. So, the government is asking everyone to exercise patience.

In the trials for the vaccine’s development, the only people who participated were non-pregnant adults. More clinical trials will take place with more diverse participants, but as of right now, health professionals do not know if the vaccine will be recommended for young children.

The COVID-19 pandemic has been a crisis for the United States and the rest of the world. This vaccine has the opportunity to drastically reduce COVID-19 cases throughout the world and put peoples’ lives back in order.